---
title: "Global Trade Concerns Weigh on Markets, SPY Down 0.08%"
canonical_url: https://www.stockexpertai.com/journal/2026-01-20/global-trade-concerns-weigh-on-markets-spy-down-008
last_updated: 2026-01-20T06:07:17.744Z
section: "Big Story"
author: "Sam Rivera"
publisher: Stock Expert AI
tickers: VALN
content_type: journal-article
---

# Global Trade Concerns Weigh on Markets, SPY Down 0.08%

## The Take
- Global trade concerns are weighing on US equities; diversify your portfolio and carefully assess risk tolerance.

_Renewed trade tensions and geopolitical uncertainty create headwinds for US equities._

Renewed concerns about global trade and geopolitical tensions are casting a shadow over U.S. equity markets. The SPY, a key ETF tracking the S&P 500, dipped slightly, down 0.08% as investors digested a mix of international headwinds. 

One major factor contributing to market unease is the resurgence of trade friction. New tariff threats linked to Greenland have sparked concerns about potential disruptions to global commerce. These developments have particularly impacted Asian markets, which traded mostly lower, reflecting the sensitivity of the region to trade-related news. Citigroup Inc. recently downgraded European equities, citing worsening relations between Brussels and Washington, further dampening investor sentiment.

Domestically, the performance across different market segments was mixed. The DIA, representing the Dow Jones Industrial Average, experienced a decline of 0.21%, while the IWM, tracking small-cap stocks, showed a slight gain of 0.09%. The QQQ, focused on technology stocks, also saw a minor decrease of 0.12%. This divergence suggests that while certain sectors may be holding up relatively well, broader market sentiment remains cautious.

Adding to the negative news, Valneva SE (VALN), a specialty vaccine company, announced it has voluntarily withdrawn its applications for its chikungunya vaccine, IXCHIQ, in the United States. This decision follows a suspension from the FDA and resulted in VALN showing a gain of 0.30%, closing at $10.07. The withdrawal highlights the challenges and regulatory hurdles faced by pharmaceutical companies in bringing new products to market.

Looking at retail investor behavior, recent data suggests a potential disconnect between favored stocks and actual performance. A portfolio of stocks popular among Indian retail traders has reportedly delivered negative returns since June 2024, raising questions about the effectiveness of popular investment strategies. This underscores the importance of thorough research and diversification, rather than solely relying on trends.

Overall, the current market environment is characterized by uncertainty. While the U.S. economy has shown resilience, global factors are creating headwinds for equities. Investors should carefully assess their risk tolerance and investment objectives in light of these developments.

The current market landscape highlights the importance of staying informed and being prepared for potential volatility. Diversification remains a key strategy for managing risk, and investors may want to consider allocating assets across different sectors and asset classes.

## Related Tickers
- [VALN](https://www.stockexpertai.com/stock/valn)

## Frequently Asked Questions

### How are global trade concerns affecting the stock market?
Renewed trade tensions and geopolitical uncertainty are creating headwinds for U.S. equity markets. Investors are reacting to new tariff threats and worsening international relations, leading to cautious sentiment and mixed performance across different market segments. Asian markets are particularly sensitive to trade-related news.

### What is the impact of Valneva's (VALN) news on its stock?
Valneva SE (VALN) announced the voluntary withdrawal of its chikungunya vaccine application in the United States. This decision, following a suspension from the FDA, resulted in VALN stock showing a gain of 0.30% despite the negative news. The market reaction highlights the complex interplay of factors influencing stock performance.

---
_AI-generated under human editorial supervision. Educational research, not financial advice._